ALL
Pharma?in?China
Pharma?Experts
Market News
Products Guide
Brand Story
-
Cellenkos Announces FDA Clearance for Trial of CK0802 for COVID-19 ARDS americanpharmaceuticalreview
June 08, 2020Cellenkos announced the US Food & Drug Administration (FDA) has cleared the way to initiate a Phase 1 clinical trial of CK0802 (Cryopreserved Cord Blood Derived T-Regulatory Cells) for treatment of COVID-19 associated acute respiratory distress syndrome. -
Cellenkos Focuses on the Development of Cell-Therapy for CoV-ARDS americanpharmaceuticalreview
March 20, 2020Cellenkos has submitted a clinical development proposal to the Biomedical Advanced Research and Development Authority (BARDA) to start a Phase 1/2 clinical trial ... -
Cellenkos to trial cell therapy for CoV-ARDS pharmaceutical-technology
March 19, 2020Cellenkos has filed a proposal with the Biomedical Advanced Research and Development Authority (BARDA) to conduct a Phase I / II clinical trial of CK0802 to treat Covid-19 ...
Pharma Sources Insight January 2025
